Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears
Alice T Epitropoulos,1 Anthony Therattil,2 Laura M Periman,3 Eric D Rosenberg4 1Ophthalmic Surgeons & Consultants of Ohio, The Eye Center of Columbus, Department of Ophthalmology, The Ohio State University Wexner Medical Center, Columbus, OH, USA; 2New York Medical College, School of Medicin...
Saved in:
Main Authors: | Epitropoulos AT, Therattil A, Periman LM, Rosenberg ED |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/9a1e72658e7c4eaeaee825f023b74bf6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
by: Pepose JS, et al.
Published: (2019) -
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
by: White DE, et al.
Published: (2020) -
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
by: White DE, et al.
Published: (2020) -
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
by: White DE, et al.
Published: (2019) -
Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
by: Torkildsen G, et al.
Published: (2017)